Streetbeat News

Franklin Covey Co.

https://www.franklincovey.com

Industry

Consulting Services

Franklin Covey Co. provides training and consulting services in the areas of execution, sales performance, productivity, customer loyalty, and educational improvement for organizations and individuals worldwide. The company operates through three segments: Direct Offices, International Licensees, and Education Practice. It also provides a suite of individual-effectiveness and leadership-development training and products. The company was incorporated in 1983 and is headquartered in Salt Lake City, Utah.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Franklin Covey (NYSE:FC) received mixed analyst ratings with a shift towards a somewhat bullish outlook, despite a decrease in the average 12-month price target from $77.50 to $62.5, indicating a 19.35% decrease. Analysts from Northland Capital Markets and Barrington Research adjusted their price targets and maintained an 'Outperform' rating. Franklin Covey's financial performance shows a negative revenue trend with a -1.4% growth over 3 months, yet it outperforms industry averages in net margin, ROE, and ROA, with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 5:01 pm

Northland Capital Markets analyst Nehal Chokshi maintains an Outperform rating on Franklin Covey (NYSE:FC) but lowers the price target from $100 to $95.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 4:25 pm

Barrington Research analyst Alexander Paris maintains an Outperform rating on Franklin Covey (NYSE:FC) but lowers the price target from $55 to $45.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 2:24 pm

Franklin Covey (NYSE:FC) reported Q2 earnings with a 20.0% beat on estimated EPS, reporting $0.06 versus an estimate of $0.05. However, revenue was down $420 thousand from the same period last year. The company's past earnings performance shows a consistent pattern of beating EPS estimates, which in the last quarter led to a 3.0% increase in share price the following day.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 8:40 pm

Franklin Covey (NYSE:FC) reported Q2 earnings of $0.06 per share, beating estimates by 20% but showing a 50% decrease from last year. Sales of $61.34M missed estimates by 1.10%, a slight decrease from the previous year.

Portfolio Pulse from dijoy@benzinga.com

March 27, 2024 | 8:38 pm

Earnings reports for March 27, 2024, include a mix of projected losses and earnings across various sectors. Notable companies like Cintas and Lands' End are expected to report earnings, while others like Local Bounti and REE Automotive anticipate losses. The diversity of industries, from biotechnology to retail, highlights the varied financial health within the market.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 9:02 am

Franklin Covey (NYSE:FC) is scheduled to release its quarterly earnings report on March 27, 2024, with an expected EPS of $0.05. Analysts and investors are keen on not just the earnings beat but also the forward guidance. Historically, FC's share price has reacted to its earnings performance, with a notable 3.28% increase following last quarter's beat. However, over the last year, FC shares have declined by 12.14%, indicating potential investor concern ahead of this release.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 2:01 pm

Barrington Research analyst Alexander Paris has reiterated an Outperform rating on Franklin Covey (NYSE:FC) and maintained a $55 price target.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 6:04 pm

Franklin Covey Co. (FC) shares dropped 4.1% in pre-market trading despite reporting Q1 earnings and revenue above estimates. The company also reaffirmed its adjusted EBITDA growth outlook for FY 2024. Other stocks experiencing pre-market losses include Applied Therapeutics (APLT), Theravance Biopharma (TBPH), Voyager Therapeutics (VYGR), Medical Properties Trust (MPW), Catalyst Pharmaceuticals (CPRX), Allogene Therapeutics (ALLO), Dyne Therapeutics (DYN), and Corporación América Airports (CAAP).

Portfolio Pulse from Avi Kapoor

January 05, 2024 | 11:19 am

U.S. stock futures are trading lower, but several companies are in focus with upcoming earnings reports and sales data. Constellation Brands is expected to report earnings of $3.00 per share on $2.54 billion revenue. Franklin Covey reported higher sales but saw a 6% drop in after-hours trading. The Greenbrier Companies are anticipated to post earnings of 73 cents per share on $849.94 million revenue. Costco Wholesale reported a 9.9% increase in December sales year-over-year. AngioDynamics is expected to report a quarterly loss of 7 cents per share on revenue of $82.04 million.

Portfolio Pulse from Avi Kapoor

January 05, 2024 | 10:24 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.